Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
暂无分享,去创建一个
M. Bonneville | H. Vié | M. Hallet | J. Even | A. Lim | N. Milpied | J. Harousseau | N Milpied | E. Goulmy | M Bonneville | E Goulmy | J Even | R. Vivien | J Gaschet | A Lim | L Liem | R Vivien | M M Hallet | J L Harousseau | H Vié | J. Gaschet | L. Liem | M. Hallet | Marc Bonneville | Annick Lim | Joëlle Gaschet | J. Harousseau | Els Goulmy | Henri Vié | Linda Liem | Noël Milpied | Jos Even
[1] H. V. van Houwelingen,et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. , 1996, The New England journal of medicine.
[2] S. Mackinnon,et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.
[3] M. Bonneville,et al. Analysis of T‐Cell Receptor Vβ Expression among Vα Subsets , 1995 .
[4] S. Snijder,et al. Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. , 1995, Human immunology.
[5] Craig W. Reynolds,et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? , 1994, Blood.
[6] P. Moreau,et al. HLA-DP and allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.
[7] M. Zöller,et al. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] G. Longton,et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. , 1993, Blood.
[9] P. Kourilsky,et al. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. , 1993, Nucleic acids research.
[10] P. Martin. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. , 1991, Bone marrow transplantation.
[11] R. Storb,et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. , 1990, Human immunology.
[12] R. Storb,et al. Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival. , 1990, Bone marrow transplantation.
[13] R. Truitt,et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. , 1990, The New England journal of medicine.
[14] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[15] R. Storb,et al. Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.
[16] K. Sullivan,et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. , 1981, The New England journal of medicine.
[17] Pepe,et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. , 1993, Blood.
[18] M. Bonneville,et al. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. , 1993, The Journal of clinical investigation.